Machine learning predicts heart failure for early treatment

Credit: ArtemisDiana/Getty
Credit: ArtemisDiana/Getty
Researchers at Rutgers University have used artificial intelligence to predict cardiovascular disease, 75% of which could be prevented if caught in time

Artificial intelligence could help predict cardiovascular diseases, such as atrial fibrillation and heart failure, in patients by analysing the genes in their DNA, according to a study by researchers at Rutgers University

Atrial fibrillation and heart failure are responsible for 45% of all cardiovascular disease deaths, and it is estimated that over 75% of premature cardiovascular diseases can be prevented. However, despite significant advancements in cardiovascular disease diagnostics, half of the affected patients die within five years of diagnosis due to genetic and environmental factors. 

AI and machine learning can help accelerate the identification of genes linked to cardiovascular disease, improving diagnoses and treatment. 

“With the successful execution of our model, we predicted the association of highly significant cardiovascular disease genes tied to demographic variables like race, gender and age,” says Zeeshan Ahmed, a core faculty member at the Rutgers Institute for Health, Health Care Policy and Aging Research (IFH) and lead author of the study, published in Genomics.

Significant differences among race, gender, and age

The researchers used AI and machine-learning models to investigate genes linked to the most common manifestations of cardiovascular disease and identified a group of genes significantly associated with the disease. The study also found significant differences among race, gender, and age factors, with age and gender factors correlating to heart failure and age and race factors correlating to atrial fibrillation.

While age and gender factors correlated to heart failure, age and race factors correlated to atrial fibrillation, say the researchers. For example, in the patients examined, the older the patient, the more likely they were to have cardiovascular disease.

“Timely understanding and precise treatment of cardiovascular disease will ultimately benefit millions of individuals by reducing the high risk for mortality and improving the quality of life,” says Ahmed.

Researchers say future research should extend this approach by analysing the full set of genes in patients with cardiovascular disease, which may reveal essential biomarkers and risk factors associated with cardiovascular disease susceptibility.

Share

Featured Articles

Samsung’s AI-Era Vision Coincides With its New Chip Tech

Samsung announced its AI-Era Vision will be fuelled by its new chip tech alongside its new Samsung AI Solutions platform

SolarWinds Report Finds Limited Business Confidence in AI

SolarWinds argues few IT professionals are confident in their organisation’s readiness to integrate AI, citing data limitations and security concerns

Apple & OpenAI: Elon Musk Threatens Apple Device Ban

The Tesla, SpaceX and xAI billionaire warns that he will ban Apple devices within his companies if Apple integrates OpenAI within its operating system

AI Now on Agenda for Apple as OpenAI to add ChatGPT to Siri

AI Strategy

AI Accelerator Offers Startups Free Use of Nvidia GPU Server

Machine Learning

How Amazon Used AI to Design the F1 Trophy

AI Applications